Nykode Therapeutics AS (FRA:5VB)
Germany · Delayed Price · Currency is EUR 0.1640
+0.0064 (4.06%)
At close: Jan 2, 2026
Nykode Therapeutics AS Market Cap
Nykode Therapeutics AS has a market cap or net worth of €63.4 million as of January 9, 2026. Its market cap has decreased by -28.33% in one year.
Market Cap
63.40M
Enterprise Value
11.54M
Revenue
6.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.16
Market Cap Chart
Since January 28, 2020, Nykode Therapeutics AS's market cap has decreased from 549.42M to 63.40M, a decrease of -88.46%. That is a compound annual growth rate of -30.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 63.40M | -4.97% |
| Dec 30, 2025 | 66.71M | -20.85% |
| Dec 30, 2024 | 84.29M | -86.48% |
| Dec 29, 2023 | 623.47M | -20.78% |
| Dec 30, 2022 | 787.04M | -66.41% |
| Dec 30, 2021 | 2.34B | 15.26% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |